Oncternal Therapeutics Inc
(ONCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 106 | 203 | 171 | 382 | 191 |
| Gross Profit | 106 | 203 | 171 | 382 | 191 |
| Operating Expenses | 9,651 | 12,346 | 12,086 | 11,707 | 11,986 |
| Operating Income | -9,545 | -12,143 | -11,915 | -11,325 | -11,795 |
| Other Income | 579 | 656 | 515 | 200 | 54 |
| Pre-tax Income | -8,966 | -11,487 | -11,400 | -11,125 | -11,741 |
| Net Income Continuous | -8,966 | -11,487 | -11,400 | -11,125 | -11,741 |
| Net Income | $-8,966 | $-11,487 | $-11,400 | $-11,125 | $-11,741 |
| EPS Basic Total Ops | -3.05 | -3.93 | -4.00 | -4.20 | -4.60 |
| EPS Basic Continuous Ops | -3.05 | -3.93 | -3.99 | -4.10 | -4.69 |
| EPS Diluted Total Ops | -3.05 | -3.93 | -4.00 | -4.20 | -4.60 |
| EPS Diluted Continuous Ops | -3.05 | -3.93 | -3.99 | -4.10 | -4.69 |
| EPS Diluted Before Non-Recurring Items | -3.00 | -4.00 | -4.00 | N/A | N/A |
| EBITDA(a) | $-10,012 | $-12,584 | $-11,915 | $-11,325 | $-11,795 |